Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hypertension Condition: Initial Therapy |
Dose: Tablet – 40/5 mg Frequency: once daily Note: Patient may be initiated on Telmisartan/Amlodipine tablets if it is unlikely that control of blood pressure would be achieved with a single agent. The usual starting dose is 40/5 mg once daily. May be administered concomitantly with other anti-hypertensive agents. Initial therapy is not recommended in patients greater than or equal to 75 years old or with hepatic impairment. |
|
Indication: Hypertension Condition: Initial Therapy (requiring larger blood pressure reductions) |
Dose: Tablet – 80/5 mg Frequency: once daily Note: Patients requiring larger blood pressure reductions may be started with 80/5 mg once daily. May be administered concomitantly with other anti-hypertensive agents. Initial therapy is not recommended in patients greater than or equal to 75 years old or with hepatic impairment. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Form – Not available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Mild to moderate impairment |
Dose: Dose: Note: Dose adjustment not recommended |
Administration
- Take with or without food
- Take in morning
Side Effect
- Peripheral edema (1-11%)
- Dizziness (3%)
- Orthostatic hypotension (6%)
- Syncope (2%)
- Back pain (2%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
-
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Biliary Obstruction, Severe Hepatic Impairment
|
Risk of liver complications
|
|
Hypotension, Cardiogenic Shock
|
Risk of dangerous blood pressure drop
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Do not store above 30°C. Protect from light and high humidity. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.